Evidence map›Paper›PMID 37444476›Full record

ArticleCancers2023

Polyploid Giant Cancer Cells Are Frequently Found in the Urine of Prostate Cancer Patients.

Laura Nalleli Garrido Castillo, Julien Anract, Nicolas Barry Delongchamps, Olivier Huillard, Fatima BenMohamed, Alessandra Decina, Thierry Lebret, Roger Dachez, Patrizia Paterlini-Bréchot

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Laura Nalleli Garrido CastilloRarecells Diagnostics, F-75015 Paris, France.ORCID 0000-0002-4249-9722
Julien AnractNational Institute for Health and Medical Research (INSERM), Institut Necker Enfants Malades-INEM, Université Paris Cité, F-75015 Paris, France.ORCID 0009-0006-7580-1066
Nicolas Barry DelongchampsNational Institute for Health and Medical Research (INSERM), Institut Necker Enfants Malades-INEM, Université Paris Cité, F-75015 Paris, France.
Olivier HuillardService de Cancérologie, AP-HP, Hôpital Cochin, F-75014 Paris, France.ORCID 0000-0001-9764-0845
Fatima BenMohamedRarecells Diagnostics, F-75015 Paris, France.
Alessandra DecinaRarecells Diagnostics, F-75015 Paris, France.
Thierry LebretService d'Onco-Urologie, Hôpital Foch, F-92150 Suresnes, France.
Roger DachezInnodiag, Pathology Laboratory, F-92100 Boulogne-Billancourt, France.
Patrizia Paterlini-BréchotRarecells Diagnostics, F-75015 Paris, France.ORCID 0000-0001-7981-6325

Funding

Rarecells Diagnostics 2020-12AB
6 · The paper itself

Abstract

Prostate cancer is the third cause of cancer-related deaths in men. Its early and reliable diagnosis is still a public health issue, generating many useless prostate biopsies. Prostate cancer cells detected in urine could be the target of a powerful test but they are considered too rare. By using an approach targeting rare cells, we have analyzed urine from 45 patients with prostate cancer and 43 healthy subjects under 50 y.o. We observed a relevant number of giant cells in patients with cancer. Giant cells, named Polyploid Giant Cancer Cells (PGCC), are thought to be involved in tumorigenesis and treatment resistance. We thus performed immune-morphological studies with cancer-related markers such as α-methylacyl-CoA racemase (AMACR), prostate-specific membrane antigen (PSMA), and telomerase reverse transcriptase (TERT) to understand if the giant cells we found are PGCC or other urinary cells. We found PGCC in the urine of 22 patients, including those with early-stage prostate cancer, and one healthy subject. Although these results are preliminary, they provide, for the first time, clinical evidence that prostate cancers release PGCC into the urine. They are expected to stimulate further studies aimed at understanding the role of urinary PGCC and their possible use as a diagnostic tool and therapeutic target.

Indexed as

biomarkersgiant cellsliquid biopsyPGCCpolyploid giant cancer cellsprostate cancerurine

Identifiers

PMID37444476
PMCPMC10340459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.